October 29, 2026 FDA, CMS target gene therapy barriers FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases. MDSpire News
October 29, 2026 FDA proposes major infant formula update after nearly 30 years Proposed changes target 4 key nutrients, requesting public input on whether additional ingredients should become mandatory. MDSpire News
October 28, 2026 FDA adds generic valganciclovir oral solution The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis. MDSpire News
October 26, 2026 FDA expands weekly insulin use to children Insulin icodec-abae offers a weekly basal insulin option for pediatric type 2 diabetes, supported by adult trials and pediatric pharmacokinetic data. MDSpire News
October 13, 2026 Alopecia therapy gains FDA breakthrough status The designation covers an investigational botanical treatment for moderate-to-severe alopecia areata in patients aged 2 years and older. MDSpire News
October 12, 2026 CDC: Measles cases surpass 4,000 in 2026 CDC data show that 96% of cases are outbreak-associated, with adults accounting for 40% of cases, up from 29% in 2025. MDSpire News
September 29, 2026 First MCT8 deficiency therapy approved Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure. MDSpire News
September 28, 2026 FDA approves new treatment for FOP Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24. MDSpire News
September 28, 2026 FDA expands treatment in nephrotic syndrome The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis. MDSpire News
September 18, 2026 FDA approves gene therapy for MPS IIIA The one-time intravenous treatment uses adeno-associated virus serotype 9 to deliver a functional copy of the SGSH gene. MDSpire News